The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial.

Front Immunol · 2026 · PMC13290605 · PMID 42358964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Following hUC-MSC infusion, T cells and NK cells showed a trend of increase at Day 7 and Day 14, while B cell counts remained relatively stable ( Figure 5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.